Colon Cancer News

Early Morning Colonoscopies Detect More Polyps (November 11, 2009)

Among patients undergoing colonoscopy at a Veteran’s Administration (VA) medical center, a greater number of polyps was detected among patients seen early in the morning than among patients seen later in the day. The reasons for this are uncertain,... Continue Reading

Excess Body Weight Linked with More Than 100,000 New Cancer Diagnoses Each Year in U.S. (November 9, 2009)

According to estimates from the American Institute for Cancer Research (AICR), excess body weight may be responsible for more than 100,000 new cancer diagnoses each year in the United States. Excess body weight is increasingly recognized as a risk factor... Continue Reading

Daily Aspirin Prevents Colorectal Cancer in Lynch Syndrome (October 5, 2009)

Daily aspirin may prevent the incidence of cancer in individuals who are genetically predisposed to hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch Syndrome, according to the results of a study presented September 21, 2009 at Europe’s... Continue Reading

Number of Obesity-related Cancers Is Growing (October 3, 2009)

In 2008, excess body weight was responsible for over 124,000 new cancer diagnoses in Europe. These results were presented at a major European cancer conference. Obesity is increasingly being recognized as a risk factor not only for cancer development,... Continue Reading

First-line Vectibix Modestly Improves Colorectal Cancer Outcome (September 25, 2009)

Among patients with metastatic colorectal cancer, initial treatment with a combination of chemotherapy and Vectibix® (panitumumab) delays cancer progression by 1.6 months compared with chemotherapy alone. This benefit, which was reported at a major European... Continue Reading

Vectibix Delays Progression of Metastatic Colorectal Cancer (September 23, 2009)

Among patients with previously treated, metastatic colorectal cancer, the addition of the targeted therapy Vectibix® (panitumumab) to chemotherapy delayed cancer progression. This benefit was only observed in patients whose tumors did not contain a mutation... Continue Reading

Addition of Vectibix® to Second-line Chemotherapy Improves Progression-free Survival in Metastatic Colorectal Cancer (August 24, 2009)

Aspirin May Improve Survival in Colon Cancer (August 17, 2009)

Regular aspirin use after a colorectal cancer diagnosis may reduce the risk of dying from the disease, especially among tumors that overexpress the COX-2 enzyme, according to the results of a study published in the Journal of the American Medical Association.[1] Previous... Continue Reading

False-positive Results Are Common with Cancer Screening (July 20, 2009)

The risk of obtaining a false-positive result from screening for prostate, lung, colorectal, and ovarian cancer is high and becomes cumulatively higher with ongoing screening—after 14 screening tests, the cumulative risk of a false-positive is 60.4%... Continue Reading

Diet and Exercise Intervention Produces Results in Long-term Survivors (July 14, 2009)

Long-term survivors of breast, colorectal, and prostate cancer who participated in a year-long home-based diet and exercise intervention reported a smaller decline in physical function compared with their counterparts who did not participate in the program,... Continue Reading